Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
LFCR
$6.51
+1.09%
LFCR
· Lifecore Biomedical, Inc. De
$6.51
+0.07 (+1.09%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$243.77M
Shares
37.85M
Volume · Oct 28
361.72K
Avg daily vol (3M)
351.48K
All webcasts
Earnings call · FY2022 Q4
Lifecore Biomedical, Inc. De (LFCR) Q4 2022 Earnings Call
Revenue
$28.11M
-37.4% YoY
Diluted EPS
-$1.88
Gross margin
37.1%
+4.6 pp YoY
Net income · derived Q4
-$55.27M
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 10, 2022.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Lifecore segment revenue
full year fiscal 2023
|
$122M – $126M | — | — | |
|
Lifecore segment adjusted EBITDA
full year fiscal 2023
|
$31M – $32.5M | Non-GAAP | — | |
|
Revenue
FY23
|
$122M – $126M | — | $103.27M below |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 10, 2022 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 16, 2023 · complete as-filed document